1 / 8

Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic

Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 u2013 2025

Marketupdates
Download Presentation

Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immuno Oncology Io Market Market Set to Exceed USD 38.89 billion by 2025 |CAGR: 21.8%

  2. Immuno Oncology Io Market Size is Estimated to reach USD 38.89 billion by 2025 “Immuno Oncology (I-O) Market Size, Trends, Industry Analysis By Treatment Approaches (Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines); By Novel Targets (IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i); By Tumor Types; By Region: Market Size & Forecast, 2020 – 2025” The global immuno-oncology market size is expected to reach USD 38.89 billion by 2025 according to a new study by Polaris Market Research. Immuno-oncology, also called as cancer immunotherapy is a biologic treatment, which enhances the body’s natural defenses to stop the growth of cancer. This therapy uses constituents made by the body or in a research laboratory to improve or reestablish the immune system function. Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. Currently, world is at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers, as well as an approved immuno-oncology medicine that continues to be studied for new uses. The more precise targeting of patients for selected therapies is another important area of focus in oncology. Clinical biomarkers and pharmacogenomic studies are increasingly used to identify groups and sub- groups of patients most likely to benefit from an investigational agent in order to maximize its potential benefits. The global immuno-oncology market is driven by the factors such as rising occurrence of different forms of cancer, technological advancements in the field of immune oncology for cancer treatment, and rising awareness concerning the benefits of ablation procedures over conventional treatment procedures. Moreover, rising number of ablation centers, surgical centers, and hospitals are driving the growth of tumor ablation market globally. Additionally, the developments in oncology treatments, leading to the increased development of pioneering products are also advancing towards significant growth of the global Immune Oncology market. Browse Detailed Research Report On Immuno Oncology Io Market: https://www.polarismarketresearch.com/industry-analysis/immuno-oncology-io-market The increasing trend was also seen in the research in the novel agents and increase in the number of clinical trials in combinations as well as monotherapy. The most notable new agents in Immuno- Oncology are IDO’s, LAG-3, TIGIT, TIM-3, VISTA, KIR, NKG2A, B7-H3/H4. The Report has also emphasized on the Oncolytic viruses, Neo-Antigen therapies, TCR Therapies and CAR-T therapies. - 2 -

  3. Immuno Oncology Io Market Size is Estimated to reach USD 38.89 billion by 2025 On the basis of treatment type, the global immuno-oncology market is segmented into Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, and Cytokines. Checkpoint inhibitors were the largest treatment process segment in 2019 that accounted for 55.2% of the overall revenue. On the basis of novel targets, the global market is segmented into IDO1i, LAG-3 CPI, oncolytic virus, STING agonist, TLR agonist, HDACi, TIL, VEGFi, MEKi, TIGIT, CPI, GITR agonist, TGF-b trap, and A2AR antagonist/CD73i. VEGFi was the largest novel target segment that was used for immuno- oncology treatment processes in 2019 with a total market share of 11.2%. on the basis of cancer type, the global immuno-oncology Market is segmented into Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Head, face & Neck Cancer, Bladder Cancer, Classical Hodgkin’s Lymphoma, Merkel Cell, and carcinoma. Revenue share of immuno-oncology treatment for classical hodgkin’s lymphoma was the largest in 2019 i.e. 15.31% among the listed tumor types in the report. On the basis of geography, North America was the largest regional market in 2019. High levels of spending on cancer treatments, also U.S. being one of the major country y with a huge population of cancer affected people on a global scale, the country being the host to the development of this technology, higher frequency of innovations of immuno oncology treatments or processes in the region specially in the U.S. etc., all of these factors have driven significant investment and alongside the demand for IO in the region. These factors have driven the North American market since the inception of this technology and over the forecast period it is expected to increase further. Some of the key players operating in global immuno-oncology market are Bristol Myers Squibb, Merck, AstraZeneca, Roche Holding AG, Pfizer Inc., and Incyte Corporation among others. - 3 -

  4. Immuno Oncology Io Market Size is Estimated to reach USD 38.89 billion by 2025 Request for sample: https://www.polarismarketresearch.com/industry-analysis/immuno- oncology-io-market/request-for-sample Table of Contents 1. Chapter 1. Introduction 1.1. Report Description 2. Chapter 2. Executive Summary 3. Chapter 3. Research Methodology Overview 3.1. Research Process 3.1.1. Information procurement 3.1.2. Purchased database: 3.1.3. Polaris Market Research’s internal database 3.2. Research Methodology 3.3. Research Scope & Assumptions 3.4. List of Data Sources 4. Chapter 4. Market Insights 4.1. Immuno Oncology: Industry Snapshot 4.2. Market Dynamics 4.3. Immuno Oncology market Forces 4.3.1. Drivers 4.3.1.1. Increasing introduction of unconventional and advanced treatment techniques 4.3.1.2. Rapidly growing population of various cancer infected patients 4.3.2. Restraints 4.3.2.1. Limited access and awareness about immunotherapy 4.3.3. Opportunity analysis: Immunology-oncology market 4.3.3.1. Increasing demand for improved cancer care by patients 4.4. Porter’s Five Forces Analysis 4.5. PEST Analysis: Immuno-Oncology Market 4.6. Five forces shaping the immuno-oncology market 5. Chapter 5. Immuno Oncology Market Estimates and Forecast, by Treatment Type 5.1. Market size by treatment type 5.2. Monoclonal Antibodies 5.2.1. Global immuno oncology monoclonal antibodies treatment market estimates & forecasts by region, 2015-2025 5.3. Therapeutic Vaccines 5.3.1. Global immuno oncology therapeutic vaccines treatment market estimates & forecasts by region, 2015-2025 5.4. Checkpoint Inhibitors 5.4.1. Global immuno oncology checkpoint inhibitors treatment market estimates & forecasts by region, 2015-2025 5.5. Cytokines 5.5.1. Global immuno oncology cytokines treatment market estimates & forecasts by region, 2015-2025 6. Chapter 6. Immuno Oncology Market Estimates and Forecast, by Novel Target Type 6.1. Market size by novel target type 6.2. IDO1i 6.2.1. Global immuno oncology market estimates & forecasts for IDO1i target by region, 2015-2025 6.3. LAG-3 CPI 6.3.1. Global immuno oncology market estimates & forecasts for LAG-3 CPI target by region, 2015-2025 6.4. Oncolytic virus - 4 -

  5. Immuno Oncology Io Market Size is Estimated to reach USD 38.89 billion by 2025 6.4.1. Global immuno oncology market estimates & forecasts for Oncolytic virus target by region, 2015-2025 6.5. STING agonist 6.5.1. Global immuno oncology market estimates & forecasts for STING agonist target by region, 2015-2025 6.6. TLR agonist 6.6.1. Global immuno oncology market estimates & forecasts for TLR agonist target by region, 2015-2025 6.7. HDACi 6.7.1. Global immuno oncology market estimates & forecasts for HDACi target by region, 2015-2025 6.8. TIL 6.8.1. Global immuno oncology market estimates & forecasts for TIL target by region, 2015-2025 6.9. VEGFi 6.9.1. Global immuno oncology market estimates & forecasts for VEGFi target by region, 2015-2025 6.10. MEKi 6.10.1. Global immuno oncology market estimates & forecasts for MEKi target by region, 2015-2025 6.11. TIGIT 6.11.1. Global immuno oncology market estimates & forecasts for TIGIT target by region, 2015-2025 6.12. CPI 6.12.1. Global immuno oncology market estimates & forecasts for CPI target by region, 2015-2025 6.13. GITR agonist 6.13.1. Global immuno oncology market estimates & forecasts for GITR agonist target by region, 2015-2025 6.14. TGF-b trap 6.14.1. Global immuno oncology market estimates & forecasts for TGF-b trap target by region, 2015-2025 6.15. A2AR antagonist/CD73i 6.15.1. Global immuno oncology market estimates & forecasts for A2AR antagonist/CD73i target by region, 2015-2025 7. Chapter 7. Immuno Oncology Market Estimates and Forecast, by Tumor or Cancer Type 7.1. Market size by tumor or cancer type 7.2. Melanoma 7.2.1. Global immuno oncology market estimates & forecasts for melanoma cancer by region, 2015-2025 7.3. Non-small cell lung cancer 7.3.1. Global immuno oncology market estimates & forecasts for non-small cell lung cancer by region, 2015-2025 7.4. Renal cell carcinoma 7.4.1. Global immuno oncology market estimates & forecasts for renal cell carcinoma cancer by region, 2015-2025 7.5. Head, face & neck cancer 7.5.1. Global immuno oncology market estimates & forecasts for head, face & neck cancer by region, 2015-2025 7.6. Bladder cancer 7.6.1. Global immuno oncology market estimates & forecasts for bladder cancer by region, 2015-2025 7.7. Classical hodgkin’s lymphoma 7.7.1. Global immuno oncology market estimates & forecasts for classical hodgkin’s lymphoma cancer by region, 2015-2025 - 5 -

  6. Immuno Oncology Io Market Size is Estimated to reach USD 38.89 billion by 2025 7.8. Merkel cell carcinoma 7.8.1. Global immuno oncology market estimates & forecasts for merkel cell carcinoma cancer by region, 2015-2025 7.9. Other cancer types 7.9.1. Global immuno oncology market estimates & forecasts for other cancer types by region, 2015-2025 8. Chapter 8. Immuno Oncology Market Estimates and Forecast, by Region 8.1. Market size by region 8.2. North America 8.2.1. North America immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.2.2. North America immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.2.3. North America immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.2.4. U.S. 8.2.4.1. U.S. immuno oncology market estimates & forecasts by treatment type, 2015- 2025 8.2.4.2. U.S. immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.2.4.3. U.S. immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.2.5. Canada 8.2.5.1. Canada immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.2.5.2. Canada immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.2.5.3. Canada immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.2.6. Mexico 8.2.6.1. Mexico immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.2.6.2. Mexico immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.2.6.3. Mexico immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.3. Europe 8.3.1. Europe immuno oncology market estimates & forecasts by treatment type, 2015- 2025 8.3.2. Europe immuno oncology market estimates & forecasts by novel target type, 2015- 2025 8.3.3. Europe immuno oncology market estimates & forecasts by tumor type, 2015-2025 8.3.4. Germany 8.3.4.1. Germany immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.3.4.2. Germany immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.3.4.3. Germany immuno oncology market estimates & forecasts by tumor type, 2015-2025 8.3.5. UK 8.3.5.1. UK immuno oncology market estimates & forecasts by treatment type, 2015- 2025 8.3.5.2. UK immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.3.5.3. UK immuno oncology market estimates & forecasts by tumor type, 2015-2025 - 6 -

  7. Immuno Oncology Io Market Size is Estimated to reach USD 38.89 billion by 2025 8.4. Asia Pacific 8.4.1. Asia Pacific immuno oncology market estimates & forecasts by treatment type, 2015- 2025 8.4.2. Asia Pacific immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.4.3. Asia Pacific immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.4.4. China 8.4.4.1. China immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.4.4.2. China immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.4.4.3. China immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.4.5. India 8.4.5.1. India immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.4.5.2. India immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.4.5.3. India immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.4.6. Japan 8.4.6.1. Japan immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.4.6.2. Japan immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.4.6.3. Japan immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.5. Central & South America (CSA) 8.5.1. CSA immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.5.2. CSA immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.5.3. CSA immuno oncology market estimates & forecasts by tumor type, 2015-2025 8.5.4. Brazil 8.5.4.1. Brazil immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.5.4.2. Brazil immuno oncology market estimates & forecasts by novel target type, 2015-2025 8.5.4.3. Brazil immuno oncology market estimates & forecasts by tumor type, 2015- 2025 8.6. Middle East & Africa (MEA) 8.6.1. MEA immuno oncology market estimates & forecasts by treatment type, 2015-2025 8.6.2. MEA immuno oncology market estimates & forecasts by novel target type, 2015- 2025 8.6.3. MEA immuno oncology market estimates & forecasts by tumor type, 2015-2025 Access Press Release on Immuno Oncology Io Market: https://www.polarismarketresearch.com/press-releases/immuno-oncology-i-o-market - 7 -

  8. Immuno Oncology Io Market Size is Estimated to reach USD 38.89 billion by 2025 About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 8 -

More Related